Development of COVID-19 vaccines utilizing gene therapy technology.

Authors:
Nakagami H.

Journal:
Int Immunol

Publication Year: 2021

DOI:
10.1093/intimm/dxab013

PMCID:
PMC8083619

PMID:
33772572

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int Immunol

Abbreviation: Int Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Cytokine signaling in chimeric antigen receptor T-cell therapy.
Kagoya Y. (2024) - Transparency Score: 3/6
Peripheral helper T cells, mavericks of peripheral immune responses.
Yoshitomi H. (2024) - Transparency Score: 3/6
Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cel…
Kawamoto H; Masuda K. (2024) - Transparency Score: 3/6
The proliferative activity levels of each immune cell population evaluated by mass cytometry are li…
Kajihara A; Morita T; Kato Y and 13 more (2023) - Transparency Score: 3/6
Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T ce…
Tatsuguchi T; Uruno T; Sugiura Y and 16 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
16.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025